ABSTRACT. Background. Prenatal and postnatal exposure to tobacco smoke adversely affects maternal and child health. Secondhand smoke (SHS) has been linked causally with sudden infant death syndrome (SIDS) in major health reports. In 1992, the US Environmental Protection Agency (EPA) first noted an association between SHS and SIDS, and both prenatal exposure and postnatal SHS exposure were listed as independent risk factors for SIDS in a 1997 California EPA report (republished in 1999 by the National Cancer Institute) and a 2004 US Surgeon General report.
P
renatal and postnatal exposure to tobacco smoke adversely affects maternal and infant health. Adverse outcomes that have been causally associated with prenatal tobacco exposure include premature rupture of membranes, preterm delivery, fetal growth restriction, and impaired pulmonary function among infants. 1 Exposure of infants and children to secondhand smoke (SHS) has also been associated with a number of adverse health outcomes, including induction and exacerbation of asthma, otitis media, and sudden infant death syndrome (SIDS). National estimates of annual pediatric morbidity and mortality rates associated with SHS exposure include 1900 to 2700 SIDS deaths, 0.7 to 1.6 million office visits for treatment of otitis media, 8000 to 26 000 new cases of asthma, 400 000 to 1 000 000 asthma exacerbations, and 150 000 to 300 000 cases of bronchitis or pneumonia among infants and toddlers. 2 SHS has been causally linked with SIDS in a number of major health reports. The landmark 1992 report from the US Environmental Protection Agency (EPA) 3 not only confirmed that SHS causes lung cancer among nonsmokers 4, 5 but also noted an association between SHS exposure and an increased risk of SIDS. Subsequent research on SIDS and smoking explored the roles of in utero exposure (prenatal), exposure to SHS after birth (postnatal), or both. In 1997, the California EPA concluded that both prenatal exposure and postnatal SHS exposure are independent risk factors for SIDS. 2 The California EPA report was republished by the National Cancer Institute (NCI) as part of its Smoking and Health Monograph Series in 1999, 6 with a preface by the US Surgeon General endorsing the report's conclusions. In 1999, a World Health Organization report called for the elimination of exposure to tobacco smoke in utero and exposure to SHS in childhood. 7 Most recently, the 2004 Surgeon General's report on smoking concluded that there is"a causal relationship between SIDS and maternal smoking during and after pregnancy." 1(pp4 -5) The tobacco industry has fought to counteract the scientific consensus that SHS is dangerous since the first evidence that SHS causes disease began to emerge in the 1970s. 8 In 1988, Philip Morris (PM), working with other multinational tobacco companies, developed an International Environmental Tobacco Smoke (ETS) Consultant Program to "keep the controversy alive" on SHS by recruiting consultants to develop and promote scientific viewpoints favorable to the industry. 9 ,10 The industry's law firm, Covington and Burling, managed the consultants' work for the tobacco industry so that the consultants' relationship with the industry could be denied or downplayed, in effect allowing consultants to be portrayed as independent third parties. The industry commissioned reports and implemented strategies to confuse or undercut the mainstream scientific literature on SHS, particularly the evidence on lung cancer. [11] [12] [13] [14] [15] Little is known about the tobacco industry's influence on maternal and child health issues.
In 2001, a scientific review of SIDS was published that acknowledged funding from PM. 16 We identified and compared 2 drafts of the review in previously secret, internal tobacco industry documents that have been made available as a result of litigation against the industry, and we noted changes made after communications between the PM scientific executives and the authors. In response to the suggestions of PM, the authors removed SHS from their original conclusion that both prenatal exposure and postnatal exposure to tobacco smoke are independent risk factors for SIDS. This industry-commissioned article may undermine efforts by clinicians, parents, and public health officials to promote the elimination of infant exposure to SHS as an important prevention strategy for SIDS.
METHODS
Tobacco industry documents include 40 million pages of internal memos and reports made public as a result of litigation settlements against the tobacco industry in the United States. Between November 2003 and January 2004, we searched tobacco industry document Internet sites from the University of California, San Francisco, Legacy Tobacco Documents Library (http:// legacy.library.ucsf.edu) and the Tobacco Documents Online website (www.tobaccodocuments.org). Searches began with general keywords such as "SIDS" and "cot" and then were narrowed with Boolean operators such as "and" to include names, dates, and reference (Bates) numbers. Names of key persons searched included "Sullivan," "Barlow," "Sanders," "Carchman," "Lee," and "Dempsey."
Two of the authors independently searched the documents and agreed on relevance through consensus. We determined that 30 documents were relevant, in that they provided either contextual information on PM's interest in SIDS or were related to the commissioning and writing of the SIDS review article.
Two drafts, namely, an early version 17 and a final version, 18 of a SIDS review by Frank Sullivan and Sue Barlow were found in the documents. The contents of these 2 drafts were compared with each other and with the final published version, 16 and changes in the text were noted. Formal comments by PM executives made in response to the first draft and submitted to Frank Sullivan were also reviewed. We used Science Citation Index in July 2004 to determine citation patterns for the referenced SIDS reviews.
RESULTS

PM Searches for Consultants on SIDS
The PM subsidiary Fabriques de Tabac Reunies (FTR) is located in Neuchatel, Switzerland, and has a Science and Technology Department (later renamed Scientific Affairs). The Science and Technology Department's 1993 mission for SHS was to support PM's corporate goals, ie, "S&T [Science and Technology] Mission: To recommend, seek approval and implement strategies for dealing with the ETS, and where appropriate, the Primary issues in support of PM global and regional business." 19 The department's activities included "Issues Tracking and Response" and "Consultant Identification and Management." Their "ETS priorities [of] 1993" included "pregnancy and childhood development, women's diseases, smoking in public buildings, mechanics of tolerant societies." 19 With the publication of the 1992 US EPA report, Helmut Reif (director of the FTR Science and Technology Department) wrote to PM executives that, as requested, he had developed proposals to address SHS issues involving indoor air quality, epidemiology, and "ETS and the family," and he suggested that consultants might be useful for certain projects.
In each case we have tried, without going into too much detail, to define the problem; our proposals for addressing the problem: and what we expect would be the benefits stemming from such work. In some cases, the ideal would be to commit to external research projects, whereas in others we feel the work could be covered by a suitable consultant, or maybe even internally. 20 The proposals for research addressing maternal and child health issues were meant to address concerns that maternal and child health issues could be used to promote the establishment of smoke-free areas.
The issues of maternal, spousal and work-place smoking all come together when considering pregnancy. In addition, women of childbearing age constitute a significant part of our market, not to mention a powerful political force. Directly mobilizing such a significant segment of the adult population around such an emotional issue has the potential for providing tremendous impetus to all sorts of restrictive legislation in the home, in public areas as well as in the workplace. There is perhaps no other issue as powerful facing the industry [emphasis added]. 21 PM wanted consultants to develop a series of literature reviews on issues such as "ETS and Pregnancy" 21 and "ETS and Physical Development in Childhood." 22 Heading each proposed topic was a description of an appropriate consultant, "To be identified [emphasis added], Head of Obstetrics, Private Practice, Regional Hospital-Pediatric Polyclinic" 21 or "Head of Pediatrics." 22 PM would be heavily involved. "Support will have to be given in terms of the definition and measurement of ETS exposure, compilation and analysis of the data, and publication." 21 The first industry-funded SIDS literature review focused only on smoking and SIDS and was written by long-time tobacco industry consultant Peter Lee and his associate Alison Thornton. 23 Lee and Thornton examined 27 studies from 1966 to 1996 and described associations between parental smoking and SIDS risk. The authors concluded that study weaknesses, in particular the failure to control properly for numerous potential confounders, "mean that a causal relationship for parental smoking in SIDS remains unproven." 23 In 1993, Lee charged the United Kingdom Tobacco Manufacturer's Association Advisory Council £12 000 for reviews on SHS and SIDS, childhood cancer, and middle ear disease. 24 In February 1997, PM paid Lee at least $2120 to publish his SIDS article. 25 However, Lee and Thornton initially encountered difficulties. In August 1997, Lee reported to the FTR Science and Technology Department 26 that he had submitted the article to Public Health Reviews but "they had rejected our SIDS paper 'considering it not sufficiently unbiased.' " 27 Because of the general difficulty of "getting tobacco industry funded studies published," 27 Lee 29 ] John Hoskins, whom I know, which has published review papers on ETS-related issues in the past. 27 In 1998, Indoor and Built Environment published the Thornton and Lee article, 23 which acknowledged that "support was provided by several companies of the tobacco industry." (Other articles by Thornton and Lee were also published in Indoor and Built Environment. [30] [31] [32] ) The SIDS review by Thornton and Lee has had little direct impact on the medical literature. As of July 2004, it had been cited only once, and that citation was by the next consultant hired by PM to write about SIDS, Frank Sullivan.
PM Commissions Toxicologist Frank Sullivan
In February 1997, as the California EPA presented its draft SHS report for public comment, PM began its search for a consultant to review the literature on SHS and SIDS. An attorney at Covington and Burling notified PM executives that the California EPA was moving toward concluding that there was a causal relationship between SHS and SIDS and that there was a "need to continue SA's [PM Scientific Affairs] ongoing work in this area." 33 Covington and Burling sent the curriculum vitae of toxicologist consultant Frank Sullivan to Ted Sanders (FTR Scientific Affairs) and asked how PM would like to proceed. 34, 35 Sanders expressed reservations about Sullivan's qualifications to Richard Carchman (director of PM Scientific Affairs), because Sullivan had no prior experience in SIDS research. 36 Previously, Sullivan had served in multiple other capacities as an industry consultant. He was listed in 1988 as one of the industry's first potential "international ETS consultants," 37, 38 and he participated in tobacco industry activities downplaying the health effects of SHS. 39, 40 In March 1997, Sanders reported to Carchman that Sullivan had expressed an interest in conducting the SIDS review. 36 PM and Sullivan agreed that literature searches would be supplied by PM and "[w]ork would be reviewed by the appropriate PM personnel on a periodic basis and the final manuscript would also be reviewed. However, Dr Sullivan would re-main free to publish the final version without restriction by Philip Morris." 36 They also agreed that "[a]ppropriate attribution for PM's support would be made," 36 which in the published article was described as only financial support. 16 In 1998, PM budgeted $50 000 to $100 000 for completion of Sullivan's review. 41, 42 The Sullivan review article was part of PM's overall scientific strategic plan for addressing SHS and childhood health issues. In January 1998, PM Worldwide Scientific Affairs described in an "Impact Assessment" how Sullivan's review would meet PM's goals: "a thorough analysis of all of the literature, not simply a review of those studies which implicate ETS . . . in order to determine if it is likely that ETS truly does play a role in the etiology of SIDS." 41 Another Worldwide Scientific Affairs project was to review the literature on SHS in childhood and organize a database of datasets for future statistical analysis. 43 The "Impact Assessment" for this project was as follows: "Should provide the necessary scientific background for a policy on the acceptability of smoking around children." In 1999, PM Worldwide Scientific Affairs listed the scientific issues of greatest importance to the company and described strategies to develop reviews for establishing PM's scientific positions. "ETS and Health" was listed as one such priority issue, with Sullivan's review being noted as already covering SIDS. 44 Besides SIDS and adult diseases such as lung cancer and cardiovascular diseases, other topics were being internally reviewed, including childhood respiratory disease and asthma. Otitis media had been covered previously by the publication by Thornton and Lee. 31 
Sullivan and PM Work Together
Sullivan worked on the SIDS review from 1997 to 2000, with his coauthor Sue Barlow; Sullivan was the direct link to PM's scientific executives. In July 1998, Sullivan wrote to Sanders that he was nearly finished with the review except for the smoking section, 45 and the 2 met soon after. 46 Sullivan's initial draft 17 was 101 pages long and reviewed 20 risk factors for SIDS. Later, in June 1999, Sanders apologized to Sullivan, as he had "just not had the opportunity to complete my work on your draft [emphasis added]" 47 and provided detailed comments from himself and Carchman (Table 1) . 48 Regarding the summary and conclusions section, Sanders' only comment on Sullivan's original conclusions was in disagreement with the role of SHS: "I would like to discuss some of the wording on this page with you. It seems that you have been less cautious in interpreting the data on postnatal ETS exposure than you were with prone sleeping position [emphasis added]." 48 Sullivan and Sanders again planned a London meeting, 47 after which Sanders sent a July 1999 memo to tobacco industry consultant Peter Lee, requesting that Lee analyze certain sections of Sullivan's draft. 49 Sanders passed on Lee's commentary to Sullivan. 50, 51 In January 2000, Sullivan wrote to Sanders that he had incorporated PM's suggestions for the final version and changed the smoking portion of the summary and conclusions section ( Table 2) . 52 Sullivan's final draft 18 included several additions and revisions that downplayed the role of smoking and especially SHS. In the revision, Sullivan removed his original conclusion that both prenatal and postnatal effects of smoking are independent risk factors for SIDS. Instead, Sullivan concluded that postnatal SHS effects were "less well established" than prenatal smoking (described below and in Tables 1 and 2 ). 18 In March 2000, Sullivan wrote to Sanders, thanking him for his "very detailed comments on the SIDS report" and reporting that "all your comments have been incorporated except for one [comment not identified]." 53 Sullivan also stated that he had communicated with the editor of the United Kingdom journal Paediatric and Perinatal Epidemiology about the review article and had received an enthusiastic response. 53 The SIDS review was published in April 2001. 16 The disclosure statement in the final publication stated, "We are grateful to Fabriques de Tabac Reunies SA (Philip Morris), Neuchatel, Switzerland, for financial support in the preparation of this review. The opinions expressed are entirely those of the authors." There is no indication in the acknowledgment that PM was involved in preparing the manuscript. 17 Sullivan's draft discussed 20 categories of SIDS risk factors. Despite Carchman's desire for "more creativity," Sullivan made few changes to these sections. However, in response to specific PM comments on smoking, 48 Sullivan incorporated some suggestions, such as noting that anemia among smoking mothers who have SIDS infants might suggest "other underlying problems" of the mother (Table 1). 18 The comments solicited from Lee by PM were incorporated into the manuscript to downplay population attributable risks for maternal smoking in SIDS. Sullivan had described a meta-analysis of 11 studies by DiFranza and Lew 54 and its calculation of population attributable risks for maternal smoking, but Sanders wrote to Sullivan, "Dr Carchman wondered if you could provide some individual critical analysis of the population attributable risks provided in this paragraph." 48 Subsequently, Sanders asked Lee for comments, which Sanders forwarded to Sullivan. 50, 51 Lee stated that the attributable risk from maternal smoking could be explained mostly by confounding. Sullivan revised his final version 18 to include Lee's comments (Table 1) , but the comments were not attributed to Lee and Lee's contributions to the article were not acknowledged. Moreover, Sullivan deleted a sentence in his conclusion stating that the population attributable risk of maternal smoking was estimated to be between 27 and 66% (Table 1 ).
Sullivan's original draft did not include the 1998 SIDS article by Thornton and Lee, 23 but the final draft 18 incorporated a descriptive paragraph about the article, stating that much of the association between tobacco exposure and SIDS appeared to be attributable to confounding (Table 3) . The article by Thornton and Lee 23 stated that the relative risks from SHS could be reduced with multiple statistical adjustments, which suggests that parental smoking and SIDS are not independently associated. In making this argument, however, Sullivan ignored the fact that, whereas proper adjustment for confounders generates a more accurate estimate of odds ratios, including excess adjustments can lead to an overspecified model and mask real associations by diluting their statistical significance. 55 Sullivan added a full paragraph criticizing the conclusion of the NCI 6 that SHS is an independent risk factor for SIDS. In January 2000, Sullivan wrote to Sanders that "the [NCI] review of the papers is ac- Page 75: I would like to discuss some of the wording on this page with you. It seems that you have been less cautious in interpreting the data on postnatal ETS exposure than you were with prone sleeping position.
Summary and Conclusions: In considering modifiable maternal risk factors, smoking is among the most important. In the majority of the many studies that have examined smoking as a risk factor, consistent associations have been found between SIDS and maternal smoking, whether smoking habits were ascertained prenatally or postnatally. The increase in crude risk rate of SIDS with maternal smoking is generally in the range 2-4 fold, which is reduced somewhat after adjusting for potential confounding variables, although it generally remains significant at close to two fold. Estimates of population attributable risk for maternal smoking range from 27-66%. In countries where maternal smoking is common and where the prevalence of infants sleeping prone has considerably declined, smoking is now considered by some investigators to be the most important modifiable risk factor. Separation of the contributions of prenatal and postnatal maternal smoking is difficult, given that the majority of women who smoke during pregnancy continue to do so afterwards. However, the evidence overall suggests that both prenatal and postnatal maternal smoking exert independent effects. The evidence overall suggests that prenatal influences on embryofetal development are likely to be most important, perhaps to modify neuromuscular and cardio-respiratory development in a manner which makes the infant less able to cope with adverse stressful situations postnatally. and that The effects of prenatal maternal smoking cannot be explained by the known effect of smoking on birth weight alone, and more subtle physiological changes are probably involved which have been demonstrated in the provocation tests discussed further below. The influence of postnatal smoking by the mother in the absence of prenatal smoking, has been difficult to assess because of the small number of women who exhibit this behaviour. Those who do smoke only postnatally tend to smoke less than the other women smokers and probably differ in other respects too. Although postnatal exposure to environmental tobacco smoke can lead to the presence of the nicotine metabolite, cotinine, in the infant, the poor correlation between urinary cotinine in the baby postnatally and SIDS risk suggests that the adverse effects of smoking are already present in the baby at birth. The influence of other smokers in the households on SIDS has been far less studied and is less clear. Again it is difficult to separate the effects of paternal from maternal smoking since both parents often smoke. Both no increase in risk and a significant increase in risk associated with the presence in the households of smokers in addition to the mother have been reported. Similarly, analysis of paternal smoking in the absence of maternal smoking has produced conflicting results with some studies finding an effect and others not. The majority of studies that have investigated the risk of SIDS in relation to numbers of cigarettes smoked have shown a dose-response relationship, both for maternal smoking during pregnancy and for maternal and/or paternal smoking postnatally. Overall, the majority much of the evidence suggests that maternal smoking is an important independent risk factor with a causal biological link to SIDS, rather than parental smoking being a surrogate for some other risk factor linked to smoking habits. The evidence for causality includes the consistent relationship between maternal/parental smoking and risk of SIDS and a clear strong dose-response relationship, Although the effects of pre-and postnatal smoke exposure are difficult to separate, the majority of the effects of smoking can be explained by prenatal smoking by the mother. together with The limited evidence of a further increase in risk from environmental tobacco smoke, such as that associated with smoking in the same room as the infant, and the presence of other smokers in the household is less well established. a reduction in risk associated with maternal cessation of smoking (whether before birth, after birth, or both). tually quite good and critical but there is a complete disconnection when they write the conclusion. . .I have expressed my feelings in our review." 52 In the final draft and publication (Table 3) , Sullivan criticized the NCI report, "The NCI report concludes . . . that environmental tobacco smoke is an independent risk factor for SIDS. This conclusion seems rather surprising in the light of the critical discussion of individual studies." 18 Sullivan added criticisms that prenatal and postnatal smoking effects were too difficult to separate. Two additional paragraphs were added to describe a 1999 Tasmanian prospective study of SIDS and cotinine (a nicotine metabolite) by Dwyer et al, 56 with an accompanying editorial by Spiers, 57 in which sources of SHS exposure at 1 month of age and subsequent risks of SIDS were examined. Sanders wrote to Sullivan, "I think that this paper is extremely important, and I also think that if at all possible it ought to be included in your review." 47 The study by Dwyer et al, 56 in which parental smoking patterns predicted urinary cotinine concentrations among the infants but not the risks of SIDS, included only 34 cases. Nevertheless, Sullivan twice emphasized the article's negative but underpowered findings as providing no evidence of an independent postnatal effect of smoking (Table 3 ). The accompanying commentary by Spiers 57 discussed the difficulty of separating prenatal and postnatal smoking effects and debated the relative contributions and mechanisms of each effect. However, Sullivan cited only Spiers' comments on the possible mechanisms for a prenatal effect (Table 3) . (No documents connect Dwyer or Spiers personally with PM.)
In the summary and conclusions section of the final draft, 18 Sullivan made a number of revisions that served to downplay the potential effects of SHS on the risks of SIDS. He deleted his original conclusion that SHS is an independent risk factor for SIDS and replaced it with statements emphasizing the prenatal effects of smoking (Tables 1 and 2 ). He deleted the sentence, "The evidence overall suggests that both prenatal and postnatal maternal smoking exert independent effects [emphasis added]." He also changed the statement, "Consistent associations have been found between SIDS and maternal smoking, whether smoking habits were ascertained prenatally or postnatally," by deleting the last phrase. He added the conclusion, "In considering modifiable maternal risk factors, smoking is among the most important," but he indicated that this does not necessarily include postnatal smoking exposure and inserted criticisms of studies of postnatal SHS exposure several times in the body of his article (Tables 1 and 2 ). He also expanded the summary and conclusions section by almost a whole paragraph to emphasize more strongly the effects of prenatal exposure on fetal development, stating that postnatal effects were "less well established" (Table 1) . 18 In summary, Sullivan substantially altered his article to focus more on abnormal infant development and the role of prenatal maternal smoking, while raising doubts about the certainty of SHS as a risk factor for SIDS. Other
We ͓Sullivan and Barlow͔ have considerably revised and updated the smoking section . . . and have taken account of all the comments at our last meeting. I have also revised the smoking section in the Summary and Conclusions section to put more emphasis on the probable prenatal effect of smoking, and less on the ETS aspect, which better reflects our opinion of the data.
Dose Response: Demonstrations of increasing risk a close association with increases in measures which attempt to estimate the degree of exposure of the infant, in utero or postnatally, between increased exposure to smoke products and risk of SIDS would contribute evidence of a causal, biological link. Summary and Conclusions: The relative lack of unexplained deaths during the first month of life suggests that prenatal factors alone are insufficient to cause SIDS and points to a possible pivotal role for postnatal factors interacting with some minor prenatal developmental anomaly, or during the rapid developmental changes that occur in infancy. Prenatal factors, such as low birth weight and maternal smoking during pregnancy, for example, undoubtedly influence the risk of SIDS. However, their influence seemingly does not become evident until well after the neonatal period, when some other compromising situation occurs, either of an external nature, such as sleeping in the prone position, and/or of an internal nature, such as occurs which coupled with an inadequate physiological response leads to a potentially life-threatening situation. In conclusion, the overall picture which emerges from this review of the factors involved in SIDS is that the affected babies are not completely normal in development, but possess some inherent weakness which may only become obvious when the infant is subjected to an unusual stress. Initially, there may be some minor impairment or delay in development of respiratory or cardiovascular regulatory centres in the brain or in the carotid body chemoreceptor mechanism. A detailed review of all of the major studies of parental smoking and SIDS has been published by . . . . The major findings of the analyses were that for maternal smoking during pregnancy, 28 of the 29 unadjusted relative risks were above 1.00 and all but 2 were statistically significant. Adjusted relative risks, when presented, were also significantly raised, but less so. In general, the more potential confounders controlled for, the greater was the reduction in risk estimate. In two of the relatively large studies (Blair et al, 1996; Mitchell et al, 1993), adjustment was made for 13 factors in each, and the reductions in excess relative risk estimate compared with unadjusted risks were 80% (4.84 to 1.78) and 79% (4.09 to 1.65), which suggests that much of the excess risk of SIDS associated with maternal smoking during pregnancy may be due to correlation of maternal smoking with other risk factors. Eight studies investigated the risks of paternal smoking, of which 6 showed significantly raised risk estimates, which were also reduced by adjustment. In one of the studies (Klonoff-Cohen et al, 1995) the relative risk when the father smoked was reported to be higher than when the mother smoked, which seems unlikely and contrary to all the other studies. NCI republication 6 However, smoking by other residents had no effect on the risk for SIDS, with or without adjustment for maternal postnatal smoking. The strongest predictor of urinary cotinine levels and of SIDS was maternal smoking (prenatal and postnatal not separable), but particular smoking behaviours, such as mother not smoking in the room with the baby and presence of other smokers, were discordant with respect to cotinine levels and prediction of SIDS. This study, while of limited power, provides no evidence that sources of postnatal exposure to tobacco smoke other than maternal smoking, were associated with SIDS. Nicotine Mechanism: Urinary cotinine levels in infants at risk for SIDS were measured in the Tasmanian Infant Health Survey (Dwyer et al, 1999) when the infants were 4-5 weeks of age, in an attempt to identify the sources of postnatal exposure to tobacco smoke, and the relation to SIDS. The strongest predictor of both cotinine and SIDS was maternal smoking. The effects of pre-and postnatal smoking could not be separated (almost all smoking mothers smoked both during and after pregnancy). However, if the mother did not smoke in the same room as the baby, the cotinine level in the infants' urine was more than halved, but this was not associated with a reduced risk of SIDS. Similarly, the presence of other adult smokers in the home was associated with a 63% increase in urinary cotinine, but not with an increase in SIDS.
Although the power of the study was inadequate to detect changes in risk of less than twofold, the authors support the suggestion that that ͓sic͔ the major effect of smoking in relation to SIDS, is a prenatal one, and not a postnatal one. The possible mechanisms involved in a prenatal effect have also been discussed by Spiers (1999) who contrasts the relative unimportance of low birthweight in SIDS deaths, compared with non-SIDS infant deaths.
* Italics were added for emphasis. OR indicates odds ratio; CI, confidence interval. Authors' notes in brackets reflect comments of this article's authors, not those of Frank Sullivan.
DISCUSSION
The tobacco industry has long fought to counteract scientific evidence that SHS is dangerous to health. Through examination of industry documents, we conclude that PM executives responded to company concerns about the possible adverse effects of SHS on maternal and child health by commissioning and influencing a review article on SIDS. The final publication included recognition that maternal smoking during pregnancy is a risk factor for SIDS, but the author's original conclusion regarding SHS was changed to state that the role of SHS is "less well established." These statements are consistent with PM's corporate position that active smoking causes disease 58 but only public health officials conclude the same for SHS. 59 ,60 The 4-line disclosure statement in the published article acknowledges financial support from PM but does not describe how PM's involvement with the author helped shape the content of the review. Moreover, the disclosure does not reflect PM's motivating concern that "there is perhaps no other issue as powerful facing the industry" as SHS and maternal and child health issues. Three years after its publication, the SIDS review by Sullivan and Barlow 16 had been cited at least 19 times in the medical literature and in an Institute of Medicine report on SIDS. 61 This citation pattern suggests that PM has succeeded in creating a review that some see as authoritative and credible and that has substantial potential to influence clinical practice and public policy.
Our analysis of the Sullivan SIDS review is relevant for institutions engaged in the debate regarding accepting or eschewing funding from the tobacco industry. Those who support acceptance of tobacco industry funds argue that academic authors retain the right to publish their work and maintain final approval of the written product, 62 but this argument fails to recognize that the tobacco industry funds work to ensure that messages favorable to the industry are published and disseminated. For example, in 1988, PM led other tobacco companies in designing and controlling an airline indoor air quality study 63 that downplayed exposure to SHS and its potential health effects when smoking restrictions on airlines were being debated. 64 In 1995, the industry generated and controlled the conduct and content of a study, eventually published under Peter Lee's name, 65 that was designed specifically to refute a landmark study on lung cancer and SHS among nonsmoking women. 13 In addition, the industry funded 15 a 2003 British Medical Journal article 66 that reported no causal relationship between SHS and lung cancer, which was criticized for being conducted in a way that almost ensured negative conclusions. 67 In each of these cases, "independent" industry consultants played a critical role in providing scientific credibility in promoting the industry's goals.
The tobacco industry's long and consistent history of manipulating the content and presentation of scientific results raises questions about publishing work funded by the tobacco industry. The International Committee of Medical Journal Editors has recommended that, in addition to identification of financial support, the role of the funding organization in the design and control of a study should be specified. 68 Paediatric and Perinatal Epidemiology, which published the article by Sullivan and Barlow, 16 requires that acknowledgments include "details of funding." The Sullivan review, 16 as well as the other cases described above, 15, 63, 64, 66, 67 illustrates the need for journals to require complete disclosure of all sponsor involvement in the conduct of a study and the preparation of the manuscript. However, such disclosure guidelines have been demonstrated repeatedly not to be effective with the tobacco industry, which seeks actively to minimize its role. 9, 69 Clinicians, parents, and public health officials may be the most vulnerable to the conclusions in Sullivan's article that SHS does not appear to be an important risk factor for SIDS. The national SIDS prevention campaign ("Back to Sleep"), sponsored by a coalition including the National Institute of Child Health and Human Development and the American Academy of Pediatrics, 70, 71 has focused mainly on the infant's sleep position. Creating a smoke-free zone around the infant is one of many secondary messages. The Back to Sleep campaign has been very successful in reducing SIDS rates, and efforts to educate parents about the importance of sleep positioning must continue. Now that the campaign is well underway, efforts to address parental smoking behavior in both the prenatal and postnatal periods should be intensified. An example of a strengthened smoke-free message is found in the US EPA "SmokeFree Home Pledge" 2001 campaign 72 to reduce children's diseases.
Clinicians need to address SHS exposure more effectively with their patients and parents. In 2001, according to a national survey of parents, only one half of all parents who visited pediatricians or family practitioners reported that they were asked about smoking status, and less than one half of the smoking parents said they were counseled about SHS or received advice to quit. 73 Although quit rates during pregnancy have been increasing in the past decade, one half of the women who quit later experience relapses in the postpartum period, and these rates have not changed with time. 74 One clinician barrier may be the perception that, as an American Academy of Pediatrics task force 71 noted in 2000, "changing [maternal smoking] behavior has been far more difficult to accomplish than changing infant sleep position." However, estimates of SIDS risks from SHS (odds ratios range from 1.4 to 5.1 75 ) have considerable overlap with estimates of risks from prone sleep positioning (odds ratios range from 1.7 to 12.9 75 ). Therefore, efforts to promote smoking cessation and reduction of SHS exposure for infants and children, particularly in discussions of SIDS prevention, should be intensified.
Clinical interventions designed to reduce SHS exposure among infants and children may be effective. A review of 19 studies (from 1987 to 2002) to reduce SHS exposure among youth concluded that these interventions can be effective. 76 In a randomized trial of a motivational intervention that included educating smoking parents, ambient nicotine concentrations in children's homes were reduced by 25 to 30%, compared with concentrations in homes where selfhelp material was provided, which resulted in no change. 77 Also encouraging is the finding that, in another study, more than one half of smoking parents tried to quit after being counseled at their children's clinic and offered nicotine replacement therapy and quit-line referrals. 78 The tobacco industry's disinformation campaign regarding SHS and maternal and child health can be counteracted within clinicians' offices. SHS must be recognized as an established, controllable, risk factor for SIDS, like prone sleep positioning. Clinicians and public health officials should intensify their efforts to promote reducing infant exposure to SHS as an effective strategy for reducing SIDS.
